Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients

BLACK HAWK, Colo. - July 21, 2020 - PRLog -- Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers.

To order this 375+ page report, which features 180+ figures and 195+ tables, please visit this link

The USD 1.7 billion financial opportunity (by 2030) within the ophthalmic drugs contract manufacturing market has been analyzed across the following segments:

§  Type of product

§  Ophthalmic API

§  Ophthalmic drug FDF

§  Type of FDF manufactured

§  Solid

§  Semi-solid

The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 report features the following companies, which we identified to be key players in this domain:

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Competitiveness Analysis

6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles

7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles

8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles

9. Clinical Trial Analysis

10. Capacity Analysis

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com